Renal Cell Carcinoma : Molecular Targets and Clinical Applications / edited by Ronald M. Bukowski, Robert A. Figlin, Robert J. Motzer.
Contributor(s): Bukowski, Ronald M, editor literario
| Figlin, Robert A., editor literario
| Motzer, Robert J, editor literario
| SpringerLink (Online service)
Material type:
E-bookPublisher: New York : Springer, 2015Edition: 3rd ed. 2015.Description: 1 recurso en línea (XVIII, 613 páginas) : 50 ilustraciones, 41 ilustraciones en color.ISBN: 9781493916221.Subject: Medicina nuclear
Abstract: The third edition of this critically acclaimed book has updated and expanded the survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. Internationally renowned editors and contributors explore the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors. Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Third Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by leaders of the field.
| Item type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RC280.K5 R463 2015 EB (Browse shelf(Opens below)) | .i11574124 | Acceso electrónico | eBOOK .i11574124 |
The third edition of this critically acclaimed book has updated and expanded the survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. Internationally renowned editors and contributors explore the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors. Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Third Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by leaders of the field.
There are no comments on this title.